7
Shared Docs
7
Same-Page
7 / 7
Mentions
c. (FHS), Olympia Therapy Inc. (Olympia), and Tridia Hospice Care Inc. (Tridia), and their executives, Brian EFTA00070439 Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission wwwjustice.gov Somehow, the DoJ didn'
Photonix and Bioptix BiOptix Diagnostics, Inc. - Portfolio company - RUSNAN O Group EFTA00070443 BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganization of state corporation Russian Corporation of Nanotechnologi
lth Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and India Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission of false claims for medically unnecess
enial covered action 2015-016/ Knight Capital TCR & Appendix In addition to NeoPhotonix and Bioptix BiOptix Diagnostics Inc. - Portfolio company - RUSNANO Group BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganizat
lth Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and India Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission of false claims for medically unnecess
enial covered action 2015-016/ Knight Capital TCR & Appendix In addition to NeoPhotonix and Bioptix BiOptix Diagnostics Inc. - Portfolio company - RUSNANO Group BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganizat
lth Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and India Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission of false claims for medically unnecess
enial covered action 2015-016/ Knight Capital TCR & Appendix In addition to NeoPhotonix and Bioptix BiOptix Diagnostics Inc. - Portfolio company - RUSNANO Group BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganizat
lth Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and India Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission of false claims for medically unnecess
enial covered action 2015-016/ Knight Capital TCR & Appendix In addition to NeoPhotonix and Bioptix BiOptix Diagnostics Inc. - Portfolio company - RUSNANO Group BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganizat
lth Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and India Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission of false claims for medically unnecess
enial covered action 2015-016/ Knight Capital TCR & Appendix In addition to NeoPhotonix and Bioptix BiOptix Diagnostics Inc. - Portfolio company - RUSNANO Group BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganizat
lth Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and India Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), have agreed to pay approximately $19.5 million to resolve allegations pertaining to the submission of false claims for medically unnecess
enial covered action 2015-016/ Knight Capital TCR & Appendix In addition to NeoPhotonix and Bioptix BiOptix Diagnostics Inc. - Portfolio company - RUSNANO Group BiOptix Diagnostics, Inc. - Portfolio company - RUSNANO Group RUSNANO was founded in March 2011 as an open joint stock company through reorganizat
Entities connected to both Daniel Parker and RUSNANO Group
Chris Dilorio
PERSON
Wilbur Ross
PERSONGottschall
PERSON
Supreme Court
ORGANIZATION
Donald Trump
PERSONBrian Colleran
PERSONRiot Blockchain
ORGANIZATIONOlympia
ORGANIZATION
Hospice
ORGANIZATIONTridia
ORGANIZATION
Julie K. Brown
PERSON
Denver
LOCATION
Barry Diller
PERSON
Jeffrey Epstein
PERSON
Bermuda
LOCATION
Santa Clara
LOCATIONRamos
PERSONIbex Ltd
ORGANIZATIONThe Resource Group
ORGANIZATIONTRG Pakastan Ltd
ORGANIZATION